LENSAR

LNSR · NASDAQ

$5.81+$0.06 (+1.04%)TodayMarket closed ·
Prev close $5.75

Latest news

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    LENSAR Q2 2026 Earnings Call: Complete Transcript

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    LENSAR Q2 EPS $0.10 Beats $(0.17) Estimate, Sales $16.495M Beat $14.650M Estimate

  • Press releaseGlobe Newswire

    LENSAR® Reports Second Quarter 2026 Results and Provides Business Update

  • Press releaseGlobe Newswire

    LENSAR® Reports First Quarter 2026 Results and Provides Business Update

  • News

    Earnings Scheduled For March 31, 2026

  • Press releaseGlobe Newswire

    LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • NewsAvi Kapoor

    Crude Oil Gains Around 2%; Elbit Systems Shares Jump On Upbeat Earnings

  • NewsAvi Kapoor

    Nasdaq Surges Over 100 Points; Academy Sports And Outdoors Posts Downbeat Earnings

  • NewsVandana Singh

    LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • Press releaseBusiness Wire

    Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

  • News

    LENSAR Agrees To Terminate Merger Agreement With Alcon Research

  • Press releaseGlobe Newswire

    LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC

  • News

    LENSAR Provides An Update On The Status Of Its Pending Acquisition By Alcon Research; Says The Co. And Alcon Continue To Cooperate With The FTC Staff In Connection With Its Request For Additional Information And Documentary Material; Expects To Close The Transaction In The First Half Of 2026

  • Press releaseGlobe Newswire

    LENSAR® Provides Update on Pending Acquisition by Alcon

  • Press releaseGlobe Newswire

    LENSAR® Reports Third Quarter 2025 Results and Provides Business Update

  • Press releasePRNewswire

    $TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of SVT, SSBK, LNSR, iCAD to Protect Their Rights

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TTNP, LNSR, ICAD on Behalf of Shareholders

  • Press releaseBusiness Wire

    LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ICAD, BSGM, SSBK on Behalf of Shareholders

  • Press releasePRNewswire

    $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger: SSBK, LNSR, iCAD and BSGM

  • NewsVandana Singh

    Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, DNB, LNSR on Behalf of Shareholders

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LSEA, FARO, LNSR, AVDX on Behalf of Shareholders

  • Press releasePRNewswire

    $TOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - DNB, BRDG, LNSR, SSBK

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, SSBK, RDUS on Behalf of Shareholders

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, DNB, BRDG on Behalf of Shareholders

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, TURN, DNB, GB on Behalf of Shareholders

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AZEK, LNSR, DNB on Behalf of Shareholders

  • Press releaseBusiness Wire

    LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AZEK, LNSR, DNB on Behalf of Shareholders

  • Press releasePRNewswire

    $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of LENSAR, Inc. - LNSR

  • Press releaseBusiness Wire

    Shareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. is Obtaining a Fair Price for Its Public Shareholders

  • Press releaseBusiness Wire

    LNSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LENSAR, Inc. Is Fair to Shareholders

  • Press releaseBusiness Wire

    Alcon Agrees to Acquire LENSAR, Inc.

  • Press releaseBusiness Wire

    LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • Press releaseBusiness Wire

    LENSAR to Participate in Two Upcoming Investor Conferences

  • Press releaseBusiness Wire

    LENSAR Reports Second Quarter 2024 Results and Provides Business Update

  • Press releaseBusiness Wire

    LENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European Union

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.